Spurious hyperphosphatemia in patients on hemodialysis with catheters.
Schiller
Brigitte
B
Satellite Laboratory Services, Redwood City, CA 94063, USA. schillerb@satellitelabs.com
Virk
Bhupinder
B
Blair
Martin
M
Wong
Amy
A
Moran
John
J
D000369:Aged, 80 and over; D001800:Blood Specimen Collection / Q000379:methods; D002404:Catheterization / Q000009:adverse effects*; D004866:Equipment Contamination; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D054559:Hyperphosphatemia / Q000139:chemically induced / Q000209:etiology*; D006435:Renal Dialysis / Q000295:instrumentation*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator